Table 2.
Treatment effects.
| Outcome measure | Stepped care | Treatment as usual | ||
|
|
Protocol-driven feedback | Feedback-on-demand |
|
|
| CISa fatigue severity | ||||
|
|
Pre | 50.78 | 50.20 | 49.69 |
|
|
Post | 35.60 | 35.68 | 34.94 |
|
|
Cohen d (95% CI)b | 1.44 (1.16-1.73) | 1.50 (1.21-1.79) | 1.41 (1.12-1.69) |
| SIP8c | ||||
|
|
Pre | 1488.56 | 1534.74 | 1593.20 |
|
|
Post | 822.09 | 797.10 | 961.32 |
|
|
Cohen d (95% CI)b | 1.09 (0.82-1.36) | 1.22 (0.94-1.50) | 0.91 (0.65-1.18) |
| SF-36d physical functioning | ||||
|
|
Pre | 62.27 | 60.54 | 60.95 |
|
|
Post | 75.34 | 77.82 | 76.54 |
|
|
Cohen d (95% CI)b | 0.58 (0.33-0.84) | 0.86 (0.59-1.12) | 0.72 (0.46-0.98) |
| SCL-90e | ||||
|
|
Pre | 154.36 | 160.20 | 161.22 |
|
|
Post | 137.69 | 140.79 | 143.65 |
|
|
Cohen d (95% CI)b | 0.42 (0.17-0.68) | 0.46 (0.21-0.72) | 0.40 (0.14-0.65) |
aCIS: Checklist Individual Strength.
bUncontrolled effect size: within-group effect. Cohen d=(Meanpre−Meanpost/pooled SD).
cSIP8: Sickness Impact Profile 8.
dSF-36: Medical Outcomes Survey Short Form-36.
eSCL-90: Symptom Checklist-90.